Ameriprise’s Vivani Medical VANI Stock Holding History

Ameriprise’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,816	Closed	-$101K	–	3970
2021 Q2	$101K	Buy	+6,816	New	+$132K	﹤0.01%	3826

Other funds holding VANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Ameriprise's VANI Position: Q3 2021 in Review

Ameriprise sold out of Vivani Medical (VANI) in Q3 2021, closing a stake of 6,816 shares — an estimated $101K sold.

Ameriprise first reported a position in VANI in Q2 2021 and held it in 1 quarter. The position peaked at $101K in Q2 2021. 39 funds tracked by Wall St. Rank hold VANI as of Q3 2021.

Ameriprise reported no remaining Vivani Medical position as of Q3 2021 after selling out during the quarter.
Ameriprise sold 6,816 Vivani Medical shares in Q3 2021, an estimated $101K.
Ameriprise first reported a position in Vivani Medical in Q2 2021 and held it in 1 quarter.
Ameriprise's Vivani Medical position peaked at $101K in Q2 2021.
39 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2021.

Based on Ameriprise's 13F filing for Q3 2021, filed 15 Nov 2021.